PEGylation and folate conjugation effects on the stability of chitosan-tripolyphosphate nanoparticles

被引:18
|
作者
Echeverri-Cuartas, Claudia E. [1 ,2 ]
Gartner, Carmina [1 ]
Lapitsky, Yakov [3 ]
机构
[1] Univ Antioquia, Grp Ciencia Mat, Fac Ciencias Exactas & Nat, Medellin, Colombia
[2] Univ EIA, Escuela Ciencias Vida, Programa Ingn Biomed, Envigado, Colombia
[3] Univ Toledo, Dept Chem Engn, Toledo, OH 43606 USA
关键词
Chitosan; Nanoparticles; Stability; Tripolyphosphate; Folic acid; PEG; POLYMERIC NANOPARTICLES; COLLOIDAL STABILITY; PARTICLE-SIZE; DELIVERY; DESIGN; IMPACT; STRATEGIES; PEG;
D O I
10.1016/j.ijbiomac.2020.04.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chitosan-based nanoparticles (Ch-NPs) prepared via ionotropic gelation of Ch with sodium tripolyphosphate (TPP) have been widely examined as potential drug carriers. Yet, recent studies have shown these particles to be unstable in model (pH 7.2-7.4) physiological media. To this end, here we explored the possibility of improving TPP-crosslinked Ch-NP stability through chemical Ch modification. Specifically, Ch samples with either 76% or 92% degrees of deacetylation (DD) were grafted with either polyethylene glycol (PEG), a hydrophilic molecule, or folic acid (F), a hydrophobic molecule. Limited variation in dispersion light scattering intensity, particle size and apparent zeta-potential, and lack of macroscopic precipitation were chosen as analytical evidence of dispersion stability. TPP titrations were performed to determine the optimal TPP:glucosamine molar ratio for preparing particles with near 200-nm diameters, which are desirable for systemic administration of drugs, cellular uptake, and enhancing NP blood circulation. Both DD and Ch modification influenced the particle formation process and the evolution in NP size and zeta-potential upon 30-day storage in virtually salt-free water at 25 degrees C and 37 degrees C, where the NPs underwent partial aggregation (along with possible dissolution and swelling) but remained colloidally dispersed. Under model physiological (pH 7.2; 163 mM ionic strength) conditions, however (where the chitosan amine groups were largely deprotonated), the particles quickly became destabilized, evidently due to particle dissolution followed by Ch precipitation. Overall, within the degrees of substitution used for this work (-1% for PEG, and 3 and 6% for F), neither PEG nor F qualitatively improved Ch-NP stability at physiological pH 7.2 conditions. Thus, application of TPP-crosslinked Ch-NPs in drug delivery (even when Ch is derivatized with PEG or F) should likely be limited to administration routes with acidic pH (at which these NPs remain stable). (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:1055 / +
页数:11
相关论文
共 50 条
  • [31] Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study
    Elham Bahreini
    Khosrow Aghaiypour
    Roghayeh Abbasalipourkabir
    Ali Rezaei Mokarram
    Mohammad Taghi Goodarzi
    Massoud Saidijam
    Nanoscale Research Letters, 9
  • [32] Data on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides
    Du, Zhiyang
    Liu, Jingbo
    Zhang, Ting
    Yu, Yiding
    Zhang, Yan
    Zhai, Jinxing
    Huang, Haitao
    Wei, Shibiao
    Ding, Long
    Liu, Boqun
    DATA IN BRIEF, 2020, 28
  • [33] Chitosan-tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity
    Servat-Medina, Leila
    Gonzalez-Gomez, Alvaro
    Reyes-Ortega, Felisa
    Oliveira Sousa, Ilza Maria
    Almeida Queiroz, Nubia de Cassia
    Wiziack Zago, Patricia Maria
    Jorge, Michelle Pedrosa
    Monteiro, Karin Maia
    de Carvalho, Joao Ernesto
    San Roman, Julio
    Foglio, Mary Ann
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 3897 - 3909
  • [34] Voltammetric Detection of Lead Using Chitosan-tripolyphosphate Crosslinked Electrode
    Heineman, Monika G.
    Goncalves, Bruna L.
    Vicenti, Juliano R. M.
    Dias, Daiane
    ANALYTICAL SCIENCES, 2019, 35 (11) : 1255 - 1261
  • [35] Rheological properties of chitosan-tripolyphosphate complexes: From suspensions to microgels
    Li, Ji
    Huang, Qingrong
    CARBOHYDRATE POLYMERS, 2012, 87 (02) : 1670 - 1677
  • [36] Voltammetric Detection of Lead Using Chitosan-tripolyphosphate Crosslinked Electrode
    Mônika G. Heineman
    Bruna L. Gonçalves
    Juliano R. M. Vicenti
    Daiane Dias
    Analytical Sciences, 2019, 35 : 1255 - 1261
  • [37] Development of Nanocomposite Films Based on Chitosan and Gelatin Loaded with Chitosan-Tripolyphosphate Nanoparticles: Antioxidant Potentials and Applications in Wound Healing
    Sawssen Hajji
    Naourez Ktari
    Riadh Ben Salah
    Sami Boufi
    Frédéric Debeaufort
    Moncef Nasri
    Journal of Polymers and the Environment, 2022, 30 : 833 - 854
  • [38] Influence of chitosan-tripolyphosphate nanoparticles on thermosensitive polymeric hydrogels: structural organization, drug release mechanisms and cytotoxicity
    Freitas Mariano, Kelli C.
    Monteiro do Nascimento, Monica H.
    Querobino, Samyr M.
    Ramos Campos, Estefania, V
    de Oliveira, Jhones L.
    Yokaichiya, Fabiano
    Franco, Margareth K. K. D.
    Alberto-Silva, Carlos
    de Paula, Eneida
    Lombello, Christiane B.
    de Lima, Renata
    Fraceto, Leonardo F.
    de Araujo, Daniele R.
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2020, 69 (09) : 592 - 603
  • [39] Bioaccessibility and antioxidant activity of curcumin after encapsulated by nano and Pickering emulsion based on chitosan-tripolyphosphate nanoparticles
    Shah, Bakht Ramin
    Zhang, Chunlan
    Li, Yan
    Li, Bin
    FOOD RESEARCH INTERNATIONAL, 2016, 89 : 399 - 407
  • [40] Sequential Photodynamic Therapy with Phthalocyanine Encapsulated Chitosan-Tripolyphosphate Nanoparticles and Flucytosine Treatment against Candida tropicalis
    Hsieh, Yi-Hsuan
    Chuang, Wen-Ching
    Yu, Kun-Hua
    Jheng, Cheng-Ping
    Lee, Cheng-, I
    PHARMACEUTICS, 2019, 11 (01)